Legislative & Executive Actions

*AdvaMed Member Log-in Required

The Coronavirus Aid, Relief, and Economic Security (CARES) Act and Keeping American Workers Paid and Employed Act 

On March 27, President Trump signed the CARES Act, which provides $330 billion in new funding for state and local government response; support for hospitals and health care workers; funding for personal protective equipment and other needed medical equipment; and support for local law enforcement, first responders, schools, universities, and affordable housing and homelessness assistance.  

The bill includes $562 million in funding for the Small Business Administration (SBA) to provide Economic Injury Disaster Loans (EIDL) to businesses for working capital and payroll.  The EIDL program is available to assist small businesses with fewer than 500 employees in all 50 states and territories. 

The Keeping American Workers Paid and Employed Act provides $350 billion in small business loans through a new Paycheck Protection Program to cover payroll costs, health care benefits and insurance contributions for companies with 500 or fewer employees. Loans of up to $10 million would be immediately available through existing SBA-certified lenders and the Treasury is authorized to expedite approval of new lenders. The bill would expand eligibility for EIDL and provide $10 billion in emergency grants to businesses that apply for an EIDL. The bill also requires SBA to pay all principal, interest and other fees on all existing SBA loan products for six months to provide small business debt relief.

AdvaMed Staff Contact: Duane Wright

Defense Production Act

On March 18, 2020, President Trump signed an executive order giving broad powers to HHS Secretary Azar to direct the production and distribution of health resources under the Defense Production Act (DPA). The Defense Production Act (DPA of 1950) focuses on enlisting entities within the domestic industry to provide materials and goods for the national defense when needed.  

AdvaMed Staff Contact: Chris White

Families First Coronavirus Response Act (FFCRA)

AdvaMed Staff Contact: Duane Wright

Coronavirus Preparedness and Response Supplemental Appropriations Act

  • March 6, 2020 | This bill provides $8.3 billion in emergency funding for federal agencies to respond to the coronavirus outbreak, including $1.9 billion for the Centers for Disease Control and Prevention (CDC) for state and local response efforts and $836 million for research at the National Institute of Allergy and Infectious Diseases (NIAID). Other highlights include:
    • $20 million for the Small Business Administration (SBA) disaster loans program (see additional information on SBA disaster loans below).
    • $61 million to the FDA for the development and review of vaccines, therapeutics, medical devices and countermeasures, to address potential supply chain interruptions, and to support enforcement of counterfeit products.
    • $500 million estimated cost for waiver of restrictions on Medicare providers allowing them to offer telehealth services to beneficiaries regardless of whether the beneficiary.
    • $3.4 billion dedicated to the research and development and contingency purchase of vaccines, therapeutics (includes over $2 billion to the Biomedical Advanced Research and Development Authority (BARDA)).

AdvaMed Staff Contact: Duane Wright

COVID-19 Coverage Coalition Letter

  • April 28, 2020 | This letter was sent to Congress highlighting opportunities to maintain and promote coverage options for employees and the uninsured through, for example, employer subsidies, COBRA coverage and HSA expansion. Read the full letter.

AdvaMed Staff Contact: Duane Wright